Michelle “Lani” Shiota, Ph.D. Professor, Department of Psychology Director, Substance use and Addiction Translational Research Network (SATRN) Arizona State University Dr. Michelle “Lani” Shiota is a Professor of Psychology at ASU conducting research on positive emotions, emotion regulation, and emotion-related mechanisms of health behavior. As Director of SATRN@ASU she guides a network of academic researchers and community partners in promoting community-engaged and interdisciplinary addiction science as well as evidence-based practice. A former junior high science teacher and teen dance instructor, Dr. Shiota also brings a unique perspective on issues related to youth substance use. Dr. Shiota’s presentation will delve into implications of basic emotion science for innovative, mechanistic research on substance use prevention, treatment, and harm reduction. Informed by psychology, neuroscience, and addiction science, the presentation will highlight distinct research questions revealed through this lens, as well as opportunities for intervention.  

The Primary Care SIG aims to engage primary care in research, develop substance use treatment interventions relevant to community-based practice, and promote the transfer of evidence-based results from substance use research into community-based practices.  

Join the CTN Translation & Implementation (T&I) SIG on May 20, 2025 (9-10am PT) for their next meeting, featuring the work of CTN-0069: Opioid Use Disorder in the Emergency Department (Project ED Health). Presenters Gail D'Onofrio, MD, MS, and David A. Fiellin, MD, will share their study approach and results, as well as considerations for integrating implementation outcome evaluations in efficacy/effectiveness protocols. Interested in attending? Reach out to Elena Rosenberg-Carlson (rosenbee@stanford.edu) for the meeting link and/or to join the SIG listserv! Read more about the presenters here (pdf)!

The Center for the Clinical Trials Network (CCTN) at the National Institute on Drug Abuse (NIDA) is hosting a virtual Quarterly Steering Committee Meeting on Tuesday, June 10, 2025 from 1:00 – 4:15 p.m. Eastern. Register for the meeting | View the agenda Once registered you will receive a confirmation email with a link to join the meeting and an option to download a calendar invitation. Please note: The event platform has changed from Zoom to Teams. Please register for the meeting early as it can take up to five minutes for the system to recognize a new registration and allow access to the meeting. If you have any questions about the meeting logistics, please contact CTNSupport@sdsolutionsllc.com. Individuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event should contact Sean Randol at (202) 258-3638 or srandol@sdsolutionsllc.com or through the Federal Relay (1-800-877-8339). Requests should be made at least five business days in advance of the event.

Join the University of Cincinnati College of Medicine Center for Addiction Research, part of the CTN Ohio Valley Node, is hosting a Summer Speaker Series. The series will highlight cutting-edge UC addiction research and UC-community collaborations related to prevention and treatment. The first session in the series will be held on June 11, 2025 from 12-1pm ET: Forming an Interprofessional Workforce to Address Opioid Use Disorder Among At-Risk Youth June 11, 2025, 12-1pm ET Host: T. John Winhusen, PhD (University of Cincinnati) Presenters: Michael D. Brubaker, PhD, LICDC-CS, NCC, School of Human Services, University of Cincinnati Kaycia Spenser, LISA, Cincinnati Children's Hospital Register here!

1.0 CME, ANCC, or Vermont OPR CE credits available! Advances in digital technology, such as mobile devices, have fundamentally changed our society and are rapidly changing how we provide substance use and mental healthcare. In this webinar from the CTN Northeast Node, part of their ongoing Science Series, Dr. Lisa Marsch, Director of the Dartmouth Center for Technology and Behavioral Health, will discuss how digital technology can provide state-of-the science, personalized behavioral healthcare anytime and anywhere.  She will review how data collected from mobile devices can provide new insights into the dynamic nature of substance use and mental health disorders in people’s daily lives and provide personalized digital therapeutic interventions to complement and extend our traditional models of care.  She will highlight the striking behavioral healthcare needs across the globe and how digital technologies can help provide scalable solutions to tackle these population-level needs.  She will provide a vision for the potential of digital technology to help redefine the future of behavioral healthcare. Register for the session here!

The Annual CPDD meeting for 2025 will be held June 14-18, 2026 in New Orleans, LA.

In this session, Kathleen T. Brady, MD, PhD, of the Medical University of South Carolina, will discuss the NIDA N Clinical Trials Network (CTN) study CTN-0108, “Transcranial Magnetic Stimulation for the Treatment of Methamphetamine/Cocaine Use Disorder,” a pilot study that aims to determine the feasibility, effectiveness, and safety for 20 sessions of repetitive transcranial magnetic stimulation (rTMS) versus sham in adults with a diagnosed methamphetamine or cocaine use disorder. Dr. Brady, co-Principal Investigator for CTN-0108, will present the rationale for the study, including the literature supporting the use of rTMS in stimulant use disorder, as well as the study methodology and preliminary results. Objectives: List 3 key research findings supporting the use of TMS in treating substance use disorders Describe at least 3 key elements of the methodology for a trial of TMS in treating simulant use disorders Identify at least 3 preliminary data points from the CTN-0108 study CME and CE credits available! Sponsored by the Western States Node and the Northwest and Pacific Southwest ATTCs. About the presenter: Kathleen T. Brady, M.D., Ph.D. Distinguished University Professor Director, South Carolina Clinical and Translational Research Institute Medical University of South Carolina Dr. Brady is an experienced clinical and translational researcher and has been conducting scientific investigations and clinical work in the field of addictions and psychiatric disorders for over 40 years. Her focus is on pharmacotherapy and neurobiology of addictions, comorbid psychiatric disorders and gender differences in addictions.  She has received numerous federal research grants and has published over 400 peer-reviewed journal articles and edited/co-edited 10 books.  She is the former Vice President for Research at the Medical University of South Carolina.  She has been a member of AAAP for over 25 years  and has served at the President of the Association for Medical Education and Research in Substance Use Disorders (AMERSA), the American Academy of Addiction Psychiatry (AAAP) and is the immediate past president of International Society of Addiction Medicine (ISAM).